外周血SII、PLR、NLR与狼疮性肾炎活动的相关研究
Correlation Study of Peripheral Blood SII, PLR, NLR and Lupus Nephritis Activity
摘要: 目的:本研究的目的是了解外周血系统性免疫性炎症指数(systemic immune-inflammation index, SII)、血小板与淋巴比率(platelet-to-lymphocyte ratio, PLR)、中性粒细胞与淋巴细胞比率(neutrophil-to- lymphocyte ratio, NLR)在狼疮性肾炎(lupus nephritis, LN)患者中的水平,并探讨其与LN疾病活动的关系。方法:本研究纳入2016年06月01日至2021年12月31日于青岛大学附属医院就诊符合美国风湿病学会(ACR)制定的SLE诊断标准并经肾活检病理诊断为LN的患者(117例)为研究对象。根据2019年SLE疾病活动指数SLEDAI 2K将LN患者分为轻度活动组(SLEDAI ≤ 9)与中重度活动组(SLEDAI > 9)。分析SII、PLR、NLR在两组间与疾病活动之间的相关性。结果:LN中重度活动组SII、PLR、NLR较轻度活动组下降(P < 0.05),SLEDAI评分与SII (r = −0.27, P = 0.003)、PLR (r = −0.22, P = 0.019)负相关,与补体C3 (r = 0.53, P = 0.000)、C4 (r = 0.52, P = 0.000)正相关。此外,基于ROC曲线,SII、PLR联合血清白蛋白、C3、24小时尿蛋白定量预测LN活动的曲线下面积可达84.3%,敏感度和特异度为76%和84%。结论:SII、PLR与LN疾病活动相关,是评估LN疾病活动的潜在指标。
Abstract: Objective: The purpose of this study was to understand the peripheral blood systemic immune- in-flammation index (SII), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), levels in patients with lupus nephritis (LN), and to investigate their relationships with LN disease activity. Methods: Patients with lupus nephritis pathologically diagnosed by renal biopsy and met the diagnostic criteria for SLE set by the American College of Rheumatology (ACR) from June 1, 2016, to December 31, 2021, at the Affiliated Hospital of Qingdao University (117 cases) were included in this study. Patients with LN were divided into mild activity group (≤9) and moderate- to-severe ac-tivity group (>9) according to the 2019 Systemic Lupus Erythematosus Disease Activity Index SLEDAI-2K. Correlations between SII, PLR, NLR, and disease activity were analyzed. Results: SII, PLR, and NLR decreased in the moderate-to-severe activity group of LN compared with the mild activity group (P < 0.05), and SLEDAI scores were negatively correlated with SII (r = −0.27, P = 0.003) and PLR (r = −0.22, P = 0.019) and positively correlated with C3 (r = 0.53, P = 0.000) and C4 (r = 0.52, P = 0.000). In addition, based on the ROC curve, the area under the curve of SII, PLR combined with albumin, C3, and 24-hour urine protein quantification predicted LN activity up to 84.3% with the sensitivity of 76% and the specificity of 84%. Conclusion: SII and PLR are associated with LN disease activity, and they are potential indicators for assessing LN disease activity.
文章引用:刘珊珊, 刘南池, 马瑞霞. 外周血SII、PLR、NLR与狼疮性肾炎活动的相关研究[J]. 临床医学进展, 2022, 12(11): 9990-9997. https://doi.org/10.12677/ACM.2022.12111440

参考文献

[1] Parikh, S., Almaani, S., Brodsky, S., et al. (2020) Update on Lupus Nephritis: Core Curriculum 2020. American Journal of Kidney Diseases, 76, 265-281. [Google Scholar] [CrossRef] [PubMed]
[2] Ding, Y., Tan, Y., Qu, Z., et al. (2020) Renal Microvascular Lesions in Lupus Nephritis. Renal Failure, 42, 19-29. [Google Scholar] [CrossRef
[3] Kwok, S. and Tsokos, G.J. (2018) New Insights into the Role of Renal Resident Cells in the Pathogenesis of Lupus Nephritis. The Korean Journal of Internal Medicine, 33, 284-289. [Google Scholar] [CrossRef] [PubMed]
[4] Suzuki, K. (2019) Chronic Inflammation as an Immunological Abnormality and Effectiveness of Exercise. Biomolecules, 9, Article No.10. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, L., Lee, G., Liu, X., et al. (2016) Long-Term Outcomes of End-Stage Kidney Disease for Patients with Lupus Nephritis. Kidney International, 89, 1337-1345. [Google Scholar] [CrossRef] [PubMed]
[6] Goilav, B., Putterman, C. and Rubinstein, B.C. (2015) Biomarkers for Kidney Involvement in Pediatric Lupus. Biomarkers in Medicine, 9, 529-543. [Google Scholar] [CrossRef] [PubMed]
[7] Morales, E., Galindo, M., Trujillo, H., et al. (2021) Update on Lupus Ne-phritis: Looking for a New Vision. Nephron, 145, 1-13. [Google Scholar] [CrossRef] [PubMed]
[8] Anders, H., Lou-tan, J., Bruchfeld, A., et al. (2019) The Management of Lupus Nephritis as Proposed by EULAR/ERA 2019 versus KDIGO 2021. Nephrology Dialysis Transplantation, gfab351. [Google Scholar] [CrossRef] [PubMed]
[9] Koutsonikoli, A., Trachana, M., Farmaki, E., et al. (2017) Novel Bi-omarkers for the Assessment of Paediatric Systemic Lupus Erythematosus Nephritis. Clinical and Experimental Immu-nology, 188, 79-85. [Google Scholar] [CrossRef] [PubMed]
[10] Maouia, A., Rebetz, J., Kapur, R., et al. (2020) The Immune Nature of Platelets Revisited. Transfusion Medicine Reviews, 34, 209-220. [Google Scholar] [CrossRef] [PubMed]
[11] Sheu, T. and Chiang, B.J. (2021) Lymphopenia, Lymphope-nia-Induced Proliferation, and Autoimmunity. International Journal of Molecular Sciences, 22, Article No. 4152. [Google Scholar] [CrossRef] [PubMed]
[12] Davidson, A. and Aranow, C. (2010) Lupus Nephritis: Lessons from Murine Models. Nature Reviews Rheumatology, 6, 13-20. [Google Scholar] [CrossRef] [PubMed]
[13] Wu, Y., Chen, Y., Yang, X., Chen, L. and Yang, Y. (2016) Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to- Lymphocyte Ratio (PLR) Were Associated with Disease Activity in Patients with Systemic Lupus Erythematosus. International Im-munopharmacology, 36, 94-99. [Google Scholar] [CrossRef] [PubMed]
[14] Düzenli, T. and Ata, E. (2020) NLR and PLR as Potential Markers of Disease Activity in Patients with Ankylosing Spondylitis? Advances in Rheuma-tology, 60, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, Z., Kong, L., Zhang, H., et al. (2021) Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis. Frontiers in Pharmacology, 12, Article 811719. [Google Scholar] [CrossRef] [PubMed]
[16] Taha, S., Samaan, S., Ibrahim, R.A., et al. (2022) Can Complete Blood Count Picture Tell Us More about the Activity of Rheumatological Diseases? Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 15, 1-11. [Google Scholar] [CrossRef] [PubMed]
[17] Maouia, A., Rebetz, J., Kapur, R. and Semple, J.W. (2020) The Immune Nature of Platelets Revisited. Transfusion Medicine Reviews, 34, 209-220. [Google Scholar] [CrossRef] [PubMed]
[18] Aringer, M., Costenbader, K., Daikh, D., et al. (2019) 2019 Euro-pean League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythe-matosus. Arthritis & Rheumatology, 71, 1400-1412. [Google Scholar] [CrossRef] [PubMed]
[19] Carli, L., Tani, C., Vagnani, S., et al. (2015) Leukopenia, Lymphopenia, and Neutropenia in Systemic Lupus Erythematosus: Prevalence and Clinical Impact—A Systematic Literature Review. Semi-nars in Arthritis and Rheumatism, 45, 190-194. [Google Scholar] [CrossRef] [PubMed]
[20] 陈敏, 李照华, 姚航田, 王彩虹, 李小峰. 系统性红斑狼疮淋巴细胞减少机制的研究进展[J]. 中华风湿病学杂志, 2017, 21(21): 849-852.
[21] Li, P., Jiang, M., Li, K., et al. (2021) Glutathione Peroxidase 4—Regulated Neutrophil Ferropto-sis Induces Systemic Autoimmunity. Nature Immunology, 22, 1107-1117. [Google Scholar] [CrossRef] [PubMed]